This protocol is judged by an institutional evaluation board, an independent team that reviews any clinical trials involving humans. If a review involves a Timetable I drug, when the board approves the protocol as ethical, the scientists must make an application for an investigational new drug (IND) selection with the FDA.Weiser urged social media